Peripheral T-Cell Lymphoma WHO tumor classification
Item
diagnosis of ptcl according to the most recent edition of the world health organization (who) classification of tumors of hematopoietic or lymphoid tissues, as follows:
boolean
C0079774 (UMLS CUI [1,1])
C1301142 (UMLS CUI [1,2])
ALK-positive anaplastic large cell lymphoma
Item
1. anaplastic large cell lymphoma (alcl), alk positive
boolean
C1332079 (UMLS CUI [1])
Anaplastic large cell lymphoma, ALK negative
Item
2. alcl, alk negative
boolean
C1332078 (UMLS CUI [1])
Angioimmunoblastic T-cell lymphoma
Item
3. angioimmunoblastic t-cell lymphoma (aitl)
boolean
C0020981 (UMLS CUI [1])
Enteropathy-Associated T-Cell Lymphoma
Item
4. enteropathy-associated t-cell lymphoma
boolean
C0456889 (UMLS CUI [1])
Nasal Type Extranodal NK/T-Cell Lymphoma
Item
5. extranodal natural killer (nk) t-cell lymphoma, nasal type
boolean
C0392788 (UMLS CUI [1])
Hepatosplenic T-cell lymphoma
Item
6. hepatosplenic t-cell lymphoma
boolean
C1333984 (UMLS CUI [1])
Peripheral T-Cell Lymphoma
Item
7. peripheral t-cell lymphoma, no otherwise specified (nos)
boolean
C0079774 (UMLS CUI [1])
Subcutaneous panniculitis-like T-cell lymphoma
Item
8. subcutaneous panniculitis-like t-cell lymphoma
boolean
C0522624 (UMLS CUI [1])
Cytotoxic Chemotherapy Systemic Quantity | Disease recurrence | Refractory Disease | Conventional Treatment Previous
Item
relapsed or are refractory to at least 1 prior systemic cytotoxic therapy. -subjects must have received conventional therapy as a prior therapy.
boolean
C0677881 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0679254 (UMLS CUI [2])
C1514815 (UMLS CUI [3])
C2945704 (UMLS CUI [4,1])
C0205156 (UMLS CUI [4,2])
ECOG performance status
Item
ecog performance status of 0-2
boolean
C1520224 (UMLS CUI [1])
Liver function | Renal function
Item
acceptable liver and renal function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Hematologic function
Item
acceptable hematologic status
boolean
C0221130 (UMLS CUI [1])
Gender
Item
female subjects must be either:
boolean
C0079399 (UMLS CUI [1])
Childbearing Potential Absent | Female Sterilization | Postmenopausal state
Item
1. of non-child-bearing potential (surgically sterilized or at least 2 years post-menopausal); or
boolean
C3831118 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0015787 (UMLS CUI [2])
C0232970 (UMLS CUI [3])
Childbearing Potential Contraceptive methods | Barrier Contraception Double | Contraception, Barrier | Spermatocidal Agents | Intrauterine Devices | Gender Partner Childbearing Potential | Gender Contraceptive methods | Gender Serum pregnancy test negative | Gender Urine pregnancy test negative
Item
2. if of child-bearing potential, subject must use an adequate method of contraception consisting of two-barrier method or one barrier method with a spermicide or intrauterine device. both females and male subjects with female partners of child-bearing potential must agree to use an adequate method of contraception for 2 weeks prior to screening, during, and at least 4 weeks after last dose of trial medication. female subjects must have a negative serum or urine pregnancy test within 72 hours prior to start of trial medication.
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0004764 (UMLS CUI [2,1])
C0205173 (UMLS CUI [2,2])
C0004764 (UMLS CUI [3])
C0037862 (UMLS CUI [4])
C0021900 (UMLS CUI [5])
C0079399 (UMLS CUI [6,1])
C0682323 (UMLS CUI [6,2])
C3831118 (UMLS CUI [6,3])
C0079399 (UMLS CUI [7,1])
C0700589 (UMLS CUI [7,2])
C0079399 (UMLS CUI [8,1])
C0430061 (UMLS CUI [8,2])
C0079399 (UMLS CUI [9,1])
C0430057 (UMLS CUI [9,2])
Breast Feeding Absent
Item
3. not breast feeding at any time during the study.
boolean
C0006147 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Informed Consent
Item
written and voluntary informed consent.
boolean
C0021430 (UMLS CUI [1])
Diagnosis
Item
diagnosis of any of the following:
boolean
C0011900 (UMLS CUI [1])
Precursor T-cell lymphoblastic lymphoma | Precursor T-Cell Lymphoblastic Leukemia
Item
1. precursor t-cell lymphoma or leukemia
boolean
C1292758 (UMLS CUI [1])
C1961099 (UMLS CUI [2])
Adult T-Cell Lymphoma/Leukemia
Item
2. adult t-cell lymphoma/leukemia (atll)
boolean
C0023493 (UMLS CUI [1])
T-Cell Prolymphocytic Leukemia
Item
3. t-cell prolymphocytic leukemia
boolean
C2363142 (UMLS CUI [1])
T-Cell Large Granular Lymphocyte Leukemia
Item
4. t-cell large granular lymphocytic leukemia
boolean
C1955861 (UMLS CUI [1])
Primary Cutaneous Anaplastic Large Cell Lymphoma
Item
5. primary cutaneous type anaplastic large cell lymphoma
boolean
C1301362 (UMLS CUI [1])
Mycosis Fungoides | Sezary Syndrome
Item
6. mycosis fungoide/sezary syndrome
boolean
C0026948 (UMLS CUI [1])
C0036920 (UMLS CUI [2])
Antineoplastic Agents | Exception Study Protocol
Item
ongoing treatment with an anticancer agent not contemplated in this protocol.
boolean
C0003392 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
Coronary Artery Disease | Myocardial Infarction
Item
any history of clinically relevant coronary artery disease or myocardial infarction within the last 3 years.
boolean
C1956346 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
Central nervous system lymphoma
Item
known central nervous system lymphoma.
boolean
C0742472 (UMLS CUI [1])
Stem cell transplant
Item
stem cell transplant less than 3 months prior to enrolment.
boolean
C1504389 (UMLS CUI [1])
Neuropathy CTCAE Grades | Neurologic Symptoms Unstable
Item
non-tolerable > grade 2 neuropathy or evidence of unstable neurological symptoms within 4 weeks of cycle 1 day 1.
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
C0235031 (UMLS CUI [2,1])
C0443343 (UMLS CUI [2,2])
Major surgery | Exception Diagnostic surgical procedure | Complete Recovery Lacking
Item
major surgery, other than diagnostic surgery, within 2 weeks prior to cycle 1 day 1, without complete recovery.
boolean
C0679637 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0522769 (UMLS CUI [2,2])
C2826210 (UMLS CUI [3,1])
C0332268 (UMLS CUI [3,2])
Cancer Other Treatment required for | Therapeutic radiology procedure | Chemotherapy | Immunotherapy
Item
other active malignancy requiring therapy such as radiation, chemotherapy, or immunotherapy.
boolean
C1707251 (UMLS CUI [1,1])
C0332121 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2])
C0392920 (UMLS CUI [3])
C0021083 (UMLS CUI [4])
Bacterial Infections Uncontrolled | Virus Diseases Uncontrolled | Mycoses Uncontrolled | Requirement Systemic therapy | HIV Infection | Hepatitis B | Hepatitis C
Item
active, uncontrolled bacterial, viral, or fungal infections, requiring systemic therapy. known infection with hiv, or an active infection with hepatitis b or hepatitis c.
boolean
C0004623 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0042769 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0026946 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C1514873 (UMLS CUI [4,1])
C1515119 (UMLS CUI [4,2])
C0019693 (UMLS CUI [5])
C0019163 (UMLS CUI [6])
C0019196 (UMLS CUI [7])